Search companies on Owler
Advanced Search
Latest news
Newsfeed
My followed companies
Followed Companies

Genomic vision develops novel diagnostic and drug discovery solutions based on nanotechnology for DNA analysis for cancer and acute diseases. Read more

17 Followers on Owler
17 Followers on Owler
17 Followers on Owler
17 Followers on Owler

Genomic vision develops novel diagnostic and drug discovery solutions based on nanotechnology for DNA analysis for cancer and acute diseases. Read more

Aaron Bensimon's photo - Co-Founder & CEO of Genomic Vision

Co-Founder & CEO

Aaron Bensimon

CEO Approval Rating

81/100

Founded:

2004

Status:

PublicIndependent CompanyNYSE EuronextGV

SIC Code:

8000 NAICS listing »

Annual Revenue
Employees
Sector

- -
Headquarters

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

The top 10 competitors in Genomic Vision's competitive set are Nabsys, Bionano Genomics, Inc., GnuBIO, PacBio, LaserGen, OncoDNA, GenapSys, Oxford Nanopore, NanoString. Together they have raised over 2.3B between their estimated 2.3K employees. Genomic Vision has 30 employees and is ranked lowest among it's top 10 competitors. The top 10 competitors average 182.

Nabsys is a top competitor of Genomic Vision. Nabsys was founded in Providence, Rhode Island} in 2004. Nabsys competes in the Health Care Services industry. Compared to Genomic Vision, Nabsys generates $2.3M more revenue.

Bionano Genomics, Inc. is Genomic Vision's #2 competitor. Bionano Genomics, Inc. is headquartered in San Diego, California, and was founded in 2003. Bionano Genomics, Inc. operates in the Pharmaceuticals industry. Bionano Genomics, Inc. generates 316% the revenue of Genomic Vision.

GnuBIO has been one of Genomic Vision's top competitors. GnuBIO is a Private company that was founded in 2009 in Cambridge, Massachusetts. GnuBIO operates in the Biotechnology industry.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is LaserGen a competitor of Genomic Vision?

I don't know

Trending News for Genomic Vision and Genomic Vision's Competitors

January 22, 2021

Global Legal Chronicle

Pacific Biosciences' Collaboration Agreement with Invitae

Wilson Sonsini Goodrich & Rosati advised Pacific Biosciences of California, Inc. on the deal. Pacific... See more »

January 21, 2021

Boston Citybizlist

Editas Medicine Prices of Offering of Common Stock

See more »

January 22, 2021

Pharmabiz

QIAGEN says its PCR tests remain accurate and effective in detecting SARSCoV2 infections

QIAGEN announced its polymerase chain reaction (PCR) tests remain accurate and effective in detecting... See more »

Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$2.7M

Genomic Vision's revenue is the ranked 12th among it's top 10 competitors. The top 10 competitors average 28.9M. Over the last one quarters, Genomic Vision's revenue has decreased by 0%. Specifically, in Q1 2020's revenue was $ < 1M.

Acquisitions

No recent acquisitions found related to Genomic Vision

Genomic Vision Funding History

$23M

Since Genomic Vision was founded in 2004, it has participated in 1 round of funding. In total Genomic Vision has raised $23.0M. Genomic Vision's funding round was on Mar 2014 for a total of $23.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

IPO
Mar 2014
$23M
-

Total Funding: $23M

Since Genomic Vision was founded in 2004, it has participated in 1 round of funding. In total Genomic Vision has raised $23.0M. Genomic Vision's funding round was on Mar 2014 for a total of $23.0M

Investments

No recent investments found related to Genomic Vision

Genomic Vision News

September 22, 2020MarketScreener

Convening of Another Extraordinary General Meeting on October 30, 2020

(marketscreener.com) Regulatory News: Genomic Vision , a company specialized in the development of in... See more »
August 11, 2020Good Stock Invest

announces the approval by its General Assembly of all the resolutions recommended by the Management Board

Regulatory News: Genomic Vision (Paris: GV) (FR0011799907 - GV, eligible for PEA-PME), company specia... See more »
July 24, 2020MarketScreener

Convening of a New Combined Shareholders' Meeting on August 10, 2020

(marketscreener.com) Regulatory News: Genomic Vision , a company specialized in in-vitro diagnostic t... See more »
July 21, 2020Good Stock Invest

Financial information for the 1st semester 2020

Regulatory News: Genomic Vision (Paris:GV) (FR0011799907 - GV, eligible for PEA-PME), a biotechnology... See more »
June 15, 2020MarketScreener

Genomic Vision:Implementation of a Financing Line via the Reserved Issuance of Convertible Notes With Warrants (OCABSA) for a Maximum of 12 Million, Subject to Shareholders' Approval

(marketscreener.com) Regulatory News: Genomic Vision , a company specialized in the development of in... See more »
May 29, 2020Acrofan

Financial Information for the First Quarter of 2020

See more »
May 21, 2020MarketScreener

Genomic Vision:2019 Annual Results

(marketscreener.com) 2019 sales up 59% Total revenue from activity almost stable at €2.3 million Oper... See more »

Genomic Vision Press Releases

December 10, 2018streetinsider

New Preliminary Results Place HPV Integration Test as Potential Biomarker for Prognosis of Cervical Cancer

Genomic Vision (Paris: GV) (FR0011799907 – GV), company specialized in the development of diagnostic ... See more »
September 10, 2018StreetInsider

Genomic Vision Achieves Second Milestone with Quest Diagnostics on SMA Carrier Testing

Genomic Vision (Paris: GV)�(FR0011799907 – GV), a company specializing in the development of diagnost... See more »
June 11, 2018StreetInsider

The Performances of the FSHD Diagnostic Assay Presented at the 2018 International FSHD Research Conference (IRC) in Las Vegas

Genomic Vision (FR0011799907 – GV) (Paris: GV), a company specializing in the development of diagnost... See more »
May 14, 2017Blackbird

Report of The IVD R&D Day of 10 May 2017

See more »
March 31, 2017BriefingWire

New Research - Genomic Vision (GV) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Market Research Report Store (MRRS) provides professional market research report.... See more »
December 1, 2015Business Wire

Genomic Vision to Present at the LD Micro Main Event

BAGNEUX, France--(BUSINESS WIRE)--Genomic Vision (Paris:GV), a French molecular diagnostics company s... See more »
November 12, 2015BUSINESS WIRE

Genomic Vision to Present at the Canaccord Genuity 2015 Medical Technology & Diagnostics Forum

BAGNEUX, France--(BUSINESS WIRE)--Genomic Vision (Paris:GV) a French molecular diagnostics company sp... See more »

Social Media

Headquarters

80-84 rue des Meuniers

Bagneux, Île-de-France92220

33-149-08-07-40

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Genomic vision develops novel diagnostic and drug discovery solutions based on nanotechnology for DNA analysis for cancer and acute diseases. Genomic Vision was founded in 2004. Genomic Vision's headquarters is located in Bagneux, Île-de-France, FR 92...

CEO

Genomic Vision's Co-Founder & CEO, Aaron Bensimon, currently has an approval rating of 81%. Genomic Vision's primary competitors are Nabsys, Bionano Genomics, Inc. & GnuBIO.

Website

genomicvision.com

Frequently Asked Questions about Genomic Vision

  1. When was Genomic Vision founded?

    Genomic Vision was founded in 2004

  2. Who is Genomic Vision's CEO?

    Genomic Vision's CEO is Aaron Bensimon

  3. How much revenue does Genomic Vision generate?

    Genomic Vision generates $2.7M in revenue

  4. How much funding does Genomic Vision have?

    Genomic Vision has historically raised $23M in funding

  1. Where is Genomic Vision's headquarters?

    Genomic Vision's headquarters is in Bagneux Île-de-France, FR

  2. How many employees does Genomic Vision have?

    Genomic Vision has 30 employees

  3. Who are Genomic Vision's competitors?

    Genomic Vision's top competitors are Nabsys, Bionano Genomics, Inc., GnuBIO
Stay up-to-date with the latest news on Genomic Vision

© 2021 Owler, Inc.